Unveiling Cathepsin B inhibition with repurposed drugs for anticancer and anti-Alzheimer's drug discovery.
Alzheimer's disease (AD) is characterized by the aggregation of amyloid β (Aβ) peptides and the formation of plaques in the brain, primarily derived from the proteolytic degradation of amyloid precursor protein (APP). Cathepsin B (CatB) is a cysteine protease that plays a pivotal role in this p...
Saved in:
Main Authors: | Mohammed Alrouji, Sabina Yasmin, Mohammed S Alshammari, Fahad A Alhumaydhi, Sharaf E Sharaf, Moyad Shahwan, Anas Shamsi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0316010 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Virtual screening and molecular dynamics simulations identify repurposed drugs as potent inhibitors of Histone deacetylase 1: Implication in cancer therapeutics.
by: Mohammed Alrouji, et al.
Published: (2025-01-01) -
Machine Learning-Assisted Drug Repurposing Framework for Discovery of Aurora Kinase B Inhibitors
by: George Nicolae Daniel Ion, et al.
Published: (2024-12-01) -
Novel 4-aminoquinazoline derivatives as new leads for anticancer drug discovery
by: Ghorab Mostafa M., et al.
Published: (2015-09-01) -
DeepDrug as an expert guided and AI driven drug repurposing methodology for selecting the lead combination of drugs for Alzheimer’s disease
by: Victor O. K. Li, et al.
Published: (2025-01-01) -
Harnessing the power of seaweed: unveiling the potential of marine algae in drug discovery
by: Leonel Pereira, et al.
Published: (2023-12-01)